Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Voyager Therapeutics, Inc. (VYGR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 13,567 shares
@ $6.99, valued at
$94.8k
|
|
| 10/02/2023 |
4
| Fahey Sandell Jacquelyn (Chief Legal Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 61,000 shares
@ $0 |
|
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 5,500 shares
@ $10.8, valued at
$59.4k
|
|
| 07/05/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $11.41, valued at
$57.1k
Exercised 5,000 options to buy
@ $2.85, valued at
$14.3k
|
|
| 06/07/2023 |
4
| PIERCE GLENN (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| MACKEY CATHERINE J (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| Vitale Nancy (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| Onyia Jude (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| Higgins Michael J (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| Colon Grace (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| GERAGHTY JAMES A (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| SCANGOS GEORGE A (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 06/07/2023 |
4
| Hyman Steven (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 05/11/2023 |
4
| SCANGOS GEORGE A (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $10.76, valued at
$473.4k
|
|
| 04/05/2023 |
4
| Sandrock Alfred (President and CEO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 7,437 shares
@ $7.83, valued at
$58.2k
|
|
| 04/05/2023 |
4
| Swartz Robin (COO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 1,259 shares
@ $7.83, valued at
$9.9k
|
|
| 03/22/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 2,193 shares
@ $7.76, valued at
$17k
|
|
| 03/22/2023 |
4
| Swartz Robin (COO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 3,654 shares
@ $7.76, valued at
$28.4k
|
|
| 03/22/2023 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 4,410 shares
@ $7.76, valued at
$34.2k
|
|
| 03/17/2023 |
4
| Swartz Robin (COO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 15,373 shares
@ $8.2, valued at
$126.1k
|
|
| 02/27/2023 |
4
| Onyia Jude (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $6.92, valued at
$304.5k
|
|
| 02/24/2023 |
4
| NEUROCRINE BIOSCIENCES INC (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Bought 4,395,588 shares
@ $8.88, valued at
$39M
|
|
| 02/22/2023 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 3,297 shares
@ $7.45, valued at
$24.6k
|
|
| 02/22/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 34,000 shares
@ $0
Sold 738 shares
@ $7.45, valued at
$5.5k
Granted 68,000 options to buy
@ $7.43, valued at
$505.2k
|
|
| 02/22/2023 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 38,000 shares
@ $0
Granted 76,000 options to buy
@ $7.43, valued at
$564.7k
|
|
| 02/22/2023 |
4
| Swartz Robin (COO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 80,000 options to buy
@ $7.43, valued at
$594.4k
|
|
| 02/22/2023 |
4
| Sandrock Alfred (President and CEO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 120,000 shares
@ $0
Granted 240,000 options to buy
@ $7.43, valued at
$1.8M
|
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 100,000 shares
@ $9.27, valued at
$927k
Sold 50,000 shares
@ $9.22, valued at
$461k
|
|
| 01/24/2023 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 100,000 shares
@ $9.15, valued at
$915k
Sold 55,000 shares
@ $9.06, valued at
$498.3k
|
|
| 01/19/2023 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 1,396 shares
@ $9.57, valued at
$13.4k
Sold 792 shares
@ $10.34, valued at
$8.2k
|
|
|
|
|